Become a MacRumors Supporter for $50/year with no ads, ability to filter front page stories, and private forums.
For what? Your doctor cant rely on your Apple Watch data. Even if the report' results are good, he will still prescribe you a laboratory test. If it is bad, he will do the same. So, at the end of the day, your Apple Watch-based report serves no purpose.
Hmm, from that example, it seems the purpose would be to prompt the doctor that a formal test might be warranted.
 
  • Like
Reactions: rp2011
Would be great if true, but this would be the unicorn in the external sensor world to pull off.. transdermal interstitial blood glucose testing is still not proven out or validated enough to be depended on so I’m going to go out on a limb and say no WAY FDA approval would come for this. It would be even less of a novelty than the SpO2 sensor. Just buy DEXCOM already and build a truly useful medical ecosystem.
Interstitial blood glucose is the basis of the Abbot device and most other CGM's. These devices are very much validated. The Dexcom system you mention as well as the Abbott Libre, arguably the two market leaders, both use interstitial fluid to measure glucose. These systems are also very much favored over traditional fingerstick testing. Continual readings vs. point in time.
I agree that a photo sensor would need to have a ton of supporting docs, testing, etc. in order to be considered accurate enough to rely on its readings in the same way one relies on Libre and Dexcom, but its not too much of a stretch to see someone with Apple's R&D managing to pull this off.
Again if accurate, this could be a game changer in terms of how diabetics approach this as well as a potential area of huge spending savings. With the average cost of Dexcom and Libre sensors being on par with the cost of an Apple watch, its not too hard to see where this would go. The sensors are only good for about 10-14 days depending on the system. The price reflects a one month supply without insurance coverage. If the allowed amounts on a sensor pack are in the $200 range with a 20% copay, a watch would pay for itself in 1 year at full retail. (Sensor packs are usually a month supply and I am guessing at the allowed charges and assuming a copay. This does not take into account deductibles and higher copays). If Apple were to partner with insurance companies offering even a 50% discount on the watch, this would equate to a huge savings for the insurance companies and consumers vs. paying for monthly supplies.
 
  • Like
Reactions: rp2011
Not possible I say. You need something wet to be able
To measure serum glucose, either blood or tissue fluid.
This is likely using some kind of light, surface moisture or skin impedance. In any case I sincerely so not think they will get a device to measure accurately enough that they get medical device approval for this purpose from any country.
 
  • Like
Reactions: urbanslaughter1997
Great to hear this is anticipated.

The health related features have been the main reason for me to purchase, and subsequently upgrade, my own Apple Watch.

I am sure we will see more along these lines in the years to come, likely well beyond anything we even imagine today.
 
Legit question, as I see a lot of folks on this tread mention the same thing you are. Is this an Apple issue? Or an Australian government one?
It's the Australian government having legislation for medical device approval that hasn't been updated since the 80's.
This means consumer grade medical devices of the sort are not allowed to be sold here.
 
  • Like
Reactions: Biglethal69
Would love if they can eventually be able to measure insulin on the apple watch as well. This might be an easier thing to clear with the FDA?

Insulin is very important for general health and detecting pre-diabetes. You can have normal glucose, but if there is a lot of insulin being pumped out to maintain that, then thats a warning sign for diabetes. Basically "HOMA-IR"
 
Why comment if its going be so ignorant?

No one is saying this is going to replace anything. What this does do, is make it feasible for a LOT more people to monitor their Glucose and potentially helping them achieve better health.

This is also HUGE for diabetics patients who might not be able to have the more 'pro' continuous monitoring devices. Now they do in terms of a watch and can still use other devices to confirm if there is a spike in their Glucose.
Only if reads accurately, otherwise will be gimmicky marketing thing, like the blood oxygen thing. My point.
 
  • Like
Reactions: urbanslaughter1997
The blood vo2 estimates are way off (for me). I can't imagine how insanely inaccurate blood sugar levels would become.
 
Ok so you seem to have a vast knowledge of diabetes ... care to explain why you excluded people who already have it?

Because we've had a lot of tech that promised non-invasive glucose monitoring, and so far it just hasn't panned out. Don't get your hopes up.

There's a difference between "can detect that the value is double or more the norm" and "can detect fluctuations of 30%". Diabetics tend to need the latter.

There are plenty out there who check their glucose levels after a meal, after a stressful situation, after (insert whatever) ... having an extra tool that would help you determine if you've spiked (even if it's a rough guesstimate) without the need to prick your finger would be a win no matter what.

But that's exactly my point: assuming this rumor is true at all, I wouldn't be surprised if the sensor can't quite reach that level of accuracy. It can tell you if your value is about 80 or about 160 (or beyond), but not if it's in between. That's IMO just not good enough for doctors to sign off on it, because it can mean a difference of multiple insulin units.

Now, my expectation here could be wrong. Perhaps Apple has found a way to make the measurements just as accurate as invasive ones. That doesn't strike me as likely, though.

Is everything in the report information that the source actually has, or (much more likely) is a limited amount of information embellished and padded out with wishful thinking? There are a lot of questions unanswered, such as:

  • precision? (e.g., 100 mg/dL? 50? 20?)
  • does it need to be calibrated?
  • there's a mention of Samsung shipping similar tech — is Apple licensing Samsung's tech? Is Samsung licensing Apple's tech? Are both licensing something from a third party? Did both just happen to have this breakthrough the same year? None of those seem very likely.


The process or I should say a chore of "pricking your finger" is not exaclty sanitary, pleasant and that's prior to covid ... this is one of the reasons why people who get diagnosed either skip checking their glucose on a consistent basis and over/under medicate.

Sure.

Other options like Dexcom do exist, though.

Naturally, a less accurate measurement is better than none at all. If the end result is that people measure once or twice a day with an invasive method, and on top of that use the Watch for quick rough measurements, fair enough.


 
  • Like
Reactions: urbanslaughter1997
Well, right now, we're talking about a dubious rumor.

If (and that's a big if) Apple makes such an announcement this fall, that'll be quite interesting.

However, there have been many "we've figured it out!" claims in non-invasive blood glucose monitoring. It's not that it's inconceivable that one day someone does figure it out, but I'd be wary of any rumor that sounds like someone's dream scenario rather than something with actual evidence.
and not to forget, for any such new technology, it will require FDA approval and that in itself will take years ...
 
Because we've had a lot of tech that promised non-invasive glucose monitoring, and so far it just hasn't panned out. Don't get your hopes up.

There's a difference between "can detect that the value is double or more the norm" and "can detect fluctuations of 30%". Diabetics tend to need the latter.



But that's exactly my point: assuming this rumor is true at all, I wouldn't be surprised if the sensor can't quite reach that level of accuracy. It can tell you if your value is about 80 or about 160 (or beyond), but not if it's in between. That's IMO just not good enough for doctors to sign off on it, because it can mean a difference of multiple insulin units.

Now, my expectation here could be wrong. Perhaps Apple has found a way to make the measurements just as accurate as invasive ones. That doesn't strike me as likely, though.

Is everything in the report information that the source actually has, or (much more likely) is a limited amount of information embellished and padded out with wishful thinking? There are a lot of questions unanswered, such as:

  • precision? (e.g., 100 mg/dL? 50? 20?)
  • does it need to be calibrated?
  • there's a mention of Samsung shipping similar tech — is Apple licensing Samsung's tech? Is Samsung licensing Apple's tech? Are both licensing something from a third party? Did both just happen to have this breakthrough the same year? None of those seem very likely.


Sure.

Other options like Dexcom do exist, though.

Naturally, a less accurate measurement is better than none at all. If the end result is that people measure once or twice a day with an invasive method, and on top of that use the Watch for quick rough measurements, fair enough.
accuracy is required for this to be effective ... people will base their insulin take-in based on those results ... therefor it will get FDA scrutiny, and it will not be built into the AW itself, maybe a "smart" band ... and I do believe that sooner or later such a sensor will exist
 
If this gets FDA approval, this will be huge for Apple and their watch customers.
yes indeed, but, assuming it does exit and will make its way into the AW: Apple will not put this into every AW model. Why? Because such technology will demand a premium. The often referred Dexcom solution for continuous glucose measurement is targeted for Type 1 and costs north of $500. Apple would create a special model that has the Ensor and it will sell for double the price. People who need it will happily pay. And, FDA approval would only be for the special model, not the entire line-up
 
This, a thousand times this. No way would this be as accurate as a Dexcom(which can/has to be recalibrated) or a actual glucose meter.
Why are people so obsessed with perfect accuracy?

Sure, maybe it's not good enough for diabetics. But there's a whole world of people who are NOT diabetics, but would like to ensure that their glucose levels remain healthy. A signal that's slightly noisy, but gives a reliable average over a few hours or so is plenty useful for informative purposes.

Apple isn't pretending to be in the "replace all your medical equipment" business; they are in the AUGMENT your health knowledge business.
 
I got covid a week ago and so have 2 family members. both ended up in hospital. They are in medical field so they had an O2 sensor at home. Whats keeping one of them at the hospital is the low O2 reading. I had no idea these gadgets were so critical. This will be a hot seller due to all the civid cases since you have to keep checking the reading throughout the day.
 
Not possible I say. You need something wet to be able
To measure serum glucose, either blood or tissue fluid.
This is likely using some kind of light, surface moisture or skin impedance. In any case I sincerely so not think they will get a device to measure accurately enough that they get medical device approval for this purpose from any country.
Of course it's possible! It was demonstrated by Princeton YEARS ago.
The issue is that what Princeton demo'd required a Quantum Cascade Laser to generate the appropriate mid-infra-red wavelength (to check how strongly that wavelength back scatters). Since then there has been on-going work to shrink QCLs (easy) and make them cheaper (less easy). But it's shrinking and cost that have stopped this becoming widespread already. There are various projects to turn this tech into medical-grade devices (where cost and size are less of an issue) though I don't believe any have yet shipped.

The alternative is to use telecomm lasers (near- rather than mid-infrared). The wavelengths are not really what one wants, but the hope has been that by using two of the standard telco wavelengths you can get a good enough SNR. I don't know how that has played out. My guess would be that
- that's what's being considered for the SS watch
- it *might* be what's considered for the Apple watch
- it's good enough to reveal long term patterns, but not good enough for people wondering about things like "does my body respond rapidly to baked potato?"

 
I'd probably wait this one out, but if this does indeed work I'd definitely get it for my Father.

However, given how flakey the O2 monitor is on AW S6.. well I hope for the best anyway.
 
T1 here. Have been wearing CGM for years and currently use Dexcom G6 with Tandem tslim x2 pump.

While I'd absolutely LOVE this rumor to be true, I do feel like it's groundhog day. Each year I read an article about this and I'm ok with that, but it's hard to get my hopes up. Reading through the entire thread, there is some good information, but there seems to be, at a high level, two groups of opinion.

1. People who do not have diabetes who would like the ability to their see blood sugar to make sure something isn't out of whack, which could point to the need for a doctor's visit. There seems to be a movement of sorts of people who are not diabetic who are purchasing CGM's (Dexcom, Freestyle Libre etc) just see the impact certain foods, activities etc has on their blood sugar for better well being. I could see this group as loving this feature as it's more of a cool thing to look at instead of an FDA approved tool.

2. Diabetics (T1's specifically, but T2's as well) who would love to see this but understand that it will likely not be accurate enough to make dosing decisions. The FDA in the past 2 years just recently approved the Dexcom G6 to make dosing decisions without the support of a fingerstick (some of us were already doing this with the previous generation G5, but it was not FDA approved or medically recommended). Also, the G6 is the first CGM produced by Dexcom (most agree they are the industry standard) that does not require finger stick calibrations during the life of the sensor (10 days).

For me (and I would assume most other T1's), UNLESS Apple pulls off one of the biggest upsets in diabetic history (LOL) and somehow has figured out how to get the FDA to approve a non-invasive glucose sensor medically accurate enough to make dosing decisions without the need of a fingerstick to verify the reading, the feature is nothing but a gimmick. I'm not saying this is a bad thing and as mentioned above, could be useful for the person interested in the trending nature of glucose and the impact certain foods, activities, stress etc. (read : EVERYTHING impacts blood glucose) have on it.

To illustrate how game changing this would be for diabetics, besides insulin, nothing is more important for my diabetes management than my Dexcom G6 CGM. It's my roadmap. I'm hoping we can get there one day, I just don't see it happening anytime soon.
 
Last edited:
yes indeed, but, assuming it does exit and will make its way into the AW: Apple will not put this into every AW model. Why? Because such technology will demand a premium. The often referred Dexcom solution for continuous glucose measurement is targeted for Type 1 and costs north of $500. Apple would create a special model that has the Ensor and it will sell for double the price. People who need it will happily pay. And, FDA approval would only be for the special model, not the entire line-up
That is certainly plausible.

The technology this involves has been mentioned in some peer reviewed journals (if I am not mistaken) but, it is not the ideal method and accuracy is in question at this point.

If Apple does release this, I think they will handle it the same way as the EKG. There is too much liability involved, especially with the method involved.
 
  • Like
Reactions: jz0309
Perhaps not for your daily usage, but maybe it could be used to send out the proper alert if things go too bad; so you're not just ignored as a drunk, or maybe even a drug user?
That would be great if it worked, but here's the problem. So much of your response to hypoglycemia depends on the individual. In theory, any reading below 80 is considered low. Someone who has been a diabetic for a long time and is no longer aware of their lows (cannot feel the difference between a low or in-range reading, could be highly functioning even down to 50 or lower. But even beyond that. It's not unusual for an inserted Continuous Glucose Monitor (CGM) to be off by as much as 50% (honestly, it happens where it's off by even more). The benefit of a CGM is for showing trends, not for identifying a moment. A CGM is good at telling you, your blood sugar is dropping or your blood sugar is rising. A CGM won't do an incredible job of telling you you're 70 vs 100 (which is an important distinction. It will, pretty reliably, tell you the direction your blood sugar moving. That is helpful information for a diabetic. I wouldn't think that would be of much interest to the Average Joe, however. Maybe I'm missing the market for this though.
 
Register on MacRumors! This sidebar will go away, and you'll see fewer ads.